Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Prostate Cancer

  Free Subscription


09.11.2020

1 Anticancer Res
1 Eur Radiol
2 Eur Urol
1 Int J Urol
2 J Natl Cancer Inst
7 J Nucl Med
3 J Urol
2 JAMA
2 PLoS One
2 Prostate


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anticancer Res

  1. BUWENGE M, Alitto AR, Cilla S, Capocaccia I, et al
    Simultaneous Integrated Radiotherapy Boost to the Dominant Intraprostatic Lesion: Final Results of a Phase I/II Trial.
    Anticancer Res. 2020;40:6499-6503.
    PubMed         Abstract available


    Eur Radiol

  2. OTTOSSON F, Baco E, Lauritzen PM, Rud E, et al
    The prevalence and locations of bone metastases using whole-body MRI in treatment-naive intermediate- and high-risk prostate cancer.
    Eur Radiol. 2020 Nov 3. pii: 10.1007/s00330-020-07363.
    PubMed         Abstract available


    Eur Urol

  3. COOPERBERG MR, Cowan JE, Lindquist KJ, Kobayashi Y, et al
    Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
    Eur Urol. 2020 Nov 1. pii: S0302-2838(20)30694.
    PubMed         Abstract available

  4. BREMBILLA G, Takwoingi Y, Kasivisvanathan V
    Tackling Interobserver Variability in Multiparametric Magnetic Resonance Imaging (MRI): Is MRI Even Better than We Think for Prostate Cancer Diagnosis?
    Eur Urol. 2020 Oct 31. pii: S0302-2838(20)30812.
    PubMed         Abstract available


    Int J Urol

  5. YOSHIDA S, Takahara T, Yokoyama M, Matsuoka Y, et al
    Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer?
    Int J Urol. 2020 Nov 2. doi: 10.1111/iju.14421.
    PubMed        


    J Natl Cancer Inst

  6. ETZIONI R, Nyame YA
    Prostate Cancer Screening Guidelines for Black Men: Spotlight on an Empty Stage.
    J Natl Cancer Inst. 2020 Nov 4. pii: 5955775. doi: 10.1093.
    PubMed        

  7. KENSLER KH, Pernar CH, Mahal BA, Nguyen PL, et al
    Racial/ethnic variation in PSA testing and prostate cancer incidence following the 2012 U.S.P.S.T.F. recommendation.
    J Natl Cancer Inst. 2020 Nov 4. pii: 5955778. doi: 10.1093.
    PubMed         Abstract available


    J Nucl Med

  8. KRATOCHWIL C, Giesel FL, Heussel CP, Kazdal D, et al
    Patients Resistant Against PSMA-Targeting alpha-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes.
    J Nucl Med. 2020;61:683-688.
    PubMed         Abstract available

  9. SEIFERT R, Kessel K, Boegemann M, Kohler M, et al
    Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy.
    J Nucl Med. 2020;61:723-728.
    PubMed         Abstract available

  10. CALDERONI L, Farolfi A, Pianori D, Maietti E, et al
    Automated synthesis module and sterile cold kit for (68)Ga-PSMA-11 do not show differences in PET/CT image quality.
    J Nucl Med. 2019 Oct 10. pii: jnumed.119.231605. doi: 10.2967/jnumed.119.231605.
    PubMed         Abstract available

  11. RATHKE H, Holland-Letz T, Mier W, Flechsig P, et al
    Response Prediction of (177)Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase.
    J Nucl Med. 2020;61:689-695.
    PubMed         Abstract available

  12. FANTI S, Hadaschik B, Herrmann K
    Proposal of Systemic Therapy Response Assessment Criteria in time of PSMA PET/CT imaging: PSMA PET Progression (PPP).
    J Nucl Med. 2019 Dec 5. pii: jnumed.119.233817. doi: 10.2967/jnumed.119.233817.
    PubMed         Abstract available

  13. FRANC BL, Iagaru A
    Letter to the Editor: "Disparities in PET imaging for prostate cancer at a tertiary academic medical center".
    J Nucl Med. 2020 Oct 30. pii: jnumed.120.258160. doi: 10.2967/jnumed.120.258160.
    PubMed        

  14. KOSTYSZYN D, Fechter T, Bartl N, Grosu AL, et al
    Intraprostatic Tumour Segmentation on PSMA-PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
    J Nucl Med. 2020 Oct 30. pii: jnumed.120.254623. doi: 10.2967/jnumed.120.254623.
    PubMed         Abstract available


    J Urol

  15. MIURA N, Mori K, Mostafaei H, Quhal F, et al
    The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis.
    J Urol. 2020;204:909-917.
    PubMed         Abstract available

  16. KANTHABALAN A, Arya M, Freeman A, Mitra AV, et al
    Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy.
    J Urol. 2020;204:950-955.
    PubMed         Abstract available

  17. PLOUSSARD G, Dumonceau O, Thomas L, Benamran D, et al
    Multi-Institutional Assessment of Routine Same Day Discharge Surgery for Robot-Assisted Radical Prostatectomy.
    J Urol. 2020;204:956-961.
    PubMed         Abstract available


    JAMA

  18. SHEN X, Pettaway CA, Chen RC
    Active Surveillance for Black Men With Low-Risk Prostate Cancer.
    JAMA. 2020;324:1733-1734.
    PubMed        

  19. DEKA R, Courtney PT, Parsons JK, Nelson TJ, et al
    Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    JAMA. 2020;324:1747-1754.
    PubMed         Abstract available


    PLoS One

  20. HAN C, Yu G, Mao Y, Song S, et al
    LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
    PLoS One. 2020;15:e0240801.
    PubMed         Abstract available

  21. NICHOLAS TR, Meng J, Greulich BM, Morris TS, et al
    --A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS.
    PLoS One. 2020;15:e0238999.
    PubMed         Abstract available


    Prostate

  22. SHIH HJ, Fang SC, An L, Shao YJ, et al
    Early-onset prostate cancer is associated with increased risks of disease progression and cancer-specific mortality.
    Prostate. 2020 Nov 5. doi: 10.1002/pros.24087.
    PubMed         Abstract available

  23. YAMOAH K, Lal P, Awasthi S, Naghavi AO, et al
    TMPRSS2-ERG fusion impact anterior tumor location in men with prostate cancer.
    Prostate. 2020 Nov 3. doi: 10.1002/pros.24086.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: